You are here

Launching of COSEQUIN® HA in Italy

22 Aug 2011
Companion Animal Health

COSEQUIN®’ HA revolutionary formula is now available in Italy thanks to BIOIBERICA’s exclusive distributor in Italy, CANDIOLI Farmaceutici, which presented COSEQUIN® HA at the 69th Edition of the SCIVAC International Congress held in Rimini (Italy) on May 27-29, 2011

COSEQUIN® HA includes the Hyal-Joint® DS molecule in its composition along with high purity chondroitin sulphate and Glucosamine HC1. Thanks to its contents in hyaluronic acid, Hyal-Join® DS increases the natural synthesis of hyaluronic acid and the maintenance of proper levels of synovial liquid, an element essential to improve joint mobility.  

 

All attendants who visited the CANDIOLI’s stand during the SCIVAC international congress were given information about the product. the people at CANDIOLI’s stand, whose motto was “All joints under control”, gave all visitors ample information about the new product’s characteristics. With this new formula, COSEQUIN® HA aims to position itself as the chondroprotection product of choice, as it gives a complete support to all structures affected by osteoarthritis: joint cartilage, subchondral bone, and synovial membrane.


Related News

25 Jan 2021
Companion Animal Health
  • The product is a supplementary food recommended to nurture growing joints in puppies, principally for fast-growing large breeds and in breeds predisposed to hip dysplasia
  • This is the third launch for the joint health area in the last three years, which renews the entire line.
30 Nov 2020
Companion Animal Health
  • This dietary supplement is recommended to protect the joints of large dog breeds
  • The product stands out for its great palatability, convenient dosage and unique composition on the market
14 Sep 2020
Companion Animal Health
  • This completes its Atopivet® range of dermatological products, both orally and topically, which help maintain the skin's integrity and protective barrier
  • There is increasing evidence that shows that the epidermal barrier function is impaired in canine atopic dermatitis